NEW PRODUCT · IN DEVELOPMENT

अनघः सर्वदर्शी — सूक्ष्मतमे जागृतिः

Anaghaḥ Sarvadarśī — Sūkṣmatame Jāgṛtiḥ

"The flawless all-seeing one — awareness at the subtlest scale."

ANAGHA

Quantum Non-Invasive Biomarker Telemetry

An always-on sentinel, smaller than a grain of sand. Sovereign-grade vigilance at the molecular frontier.

SentinelVita
WHAT IT IS

A new sovereign capability.

ANAGHA is a flawless-precision research chip — non-invasive, continuous, sovereign. It senses molecular signal at the subtlest scale, feeds twin-coupled prognosis models, and forms the sensor mesh for a national epidemic-intelligence grid.

Self-diagnosing nano-scale research-grade telemetry enabling early prognosis modeling and epidemic intelligence grids.

RIDES ON THE ONE PLATFORM

Built on the GAMIE intelligence core.

Telemetry streams land in GAMIE ingest, are reconciled against twin-state in VAIKUNTHA, and surface in Sentinel dashboards as molecular anomaly signals.

Engines powering ANAGHA

  • MEDHxRESTNET50
  • MEDHxBERT
  • MEDHxLLamaXOpenHathi
Read the platform architecture
CAPABILITIES

What ships inside ANAGHA.

01

Nano-scale biomarker telemetry

Continuous, non-invasive sensing of molecular markers relevant to longevity and infection research.

02

Self-diagnosing sensor mesh

On-chip integrity reasoning and signal-quality scoring eliminate downstream noise.

03

Twin-coupled prognosis

Streams into VAIKUNTHA-class digital twins for continuous prognosis modeling.

04

National epidemic mesh

Distributed deployment forms a sovereign-grade epidemic-intelligence grid with sub-day signal latency.

05

Air-gappable ingest

Telemetry pipelines designed for sovereign or hardened defense deployments.

STRATEGIC IMPACT

Sovereign-relevant by design.

Sovereign biosecurity gains a molecular-resolution mesh. Longevity research escapes the constraints of episodic measurement.

Customer profiles

  • 01National epidemic-intelligence directorates
  • 02Sovereign longevity research clouds
  • 03Defense biosurveillance units
  • 04Tier-1 hospital research labs
DEVELOPMENT STATUS

In active research and development.

Sovereign design partners are being onboarded selectively. Reach out to align on capability fit and deployment cadence.

In development
PARTNER WITH MEDHINI

Co-develop ANAGHA as a sovereign asset.